These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550 [TBL] [Abstract][Full Text] [Related]
24. [Outcome in cervical recurrences of papillary or follicular thyroid cancer]. Mirallié E; Hamy A; Floch I; Sagan C; Paineau J; Murat A; Le Néel JC; Visset J Ann Chir; 1999; 53(7):577-82. PubMed ID: 10520496 [TBL] [Abstract][Full Text] [Related]
25. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma. Khan S; Dunn J; Strickland N; Al-Nahhas A Nucl Med Rev Cent East Eur; 2008; 11(1):30-3. PubMed ID: 19173186 [TBL] [Abstract][Full Text] [Related]
26. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course]. Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307 [TBL] [Abstract][Full Text] [Related]
27. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin. Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210 [TBL] [Abstract][Full Text] [Related]
28. Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatment. Soydal C; Araz M; Ozkan E; Arslantaş E; Kucuk ON; Aras G Nucl Med Commun; 2015 Feb; 36(2):109-13. PubMed ID: 25321158 [TBL] [Abstract][Full Text] [Related]
29. Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer. Ahn BC; Lee SW; Lee J; Kim C Thyroid; 2011 May; 21(5):555-8. PubMed ID: 21449768 [TBL] [Abstract][Full Text] [Related]
30. False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs. Regalbuto C; Buscema M; Arena S; Vigneri R; Squatrito S; Pezzino V J Nucl Med; 2002 Feb; 43(2):207-9. PubMed ID: 11850486 [TBL] [Abstract][Full Text] [Related]
31. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma. Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642 [TBL] [Abstract][Full Text] [Related]
32. The utility of I-123 pretherapy scan in I-131 radioiodine therapy for thyroid cancer. Chen MK; Yasrebi M; Samii J; Staib LH; Doddamane I; Cheng DW Thyroid; 2012 Mar; 22(3):304-9. PubMed ID: 22300251 [TBL] [Abstract][Full Text] [Related]
35. False-positive uptake of 124I in a laryngeal cyst mimicking thyroid remnant after thyroidectomy and 131i therapy for follicular thyroid carcinoma. Noordman BJ; Comans E; Lips P; Rinkel RN Clin Nucl Med; 2014 Oct; 39(10):898-9. PubMed ID: 24561682 [TBL] [Abstract][Full Text] [Related]
36. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Karam M; Gianoukakis A; Feustel PJ; Cheema A; Postal ES; Cooper JA Nucl Med Commun; 2003 May; 24(5):489-95. PubMed ID: 12717064 [TBL] [Abstract][Full Text] [Related]